We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NICE Guidance Links Cost-Effectiveness of Osteoporosis Treatments with Fracture Risk
NICE Guidance Links Cost-Effectiveness of Osteoporosis Treatments with Fracture Risk
New guidance from the UK’s National Institute of Health and Care Excellence links the cost-effectiveness of different bisphosphonate medications for osteoporosis with a patient’s 10-year risk of bone fractures.
